You are looking for

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

Even in 2019, cardiovascular diseases (CVD) remain the number 1 killer globally, accounting for almost 2 million deaths in the EU alone every year. These diseases are linked to huge inequalities, with more cardiovascular-related deaths in women than men, and more CVD-related deaths in middle-income than high-income countries, as a recent study from the European […]

Our recently published report examining the available treatment options for Atrial Fibrillation (AF) across Europe has found that millions of patients suffering with the condition don’t have access to a potentially life-saving treatment — catheter ablation therapy. Currently, 11 million people in Europe are affected by AF, a condition characterized by an irregular and often […]

World Heart Day is approaching and it deserves to be highlighted that as patient advocates in the heart valve disease sector, our relationship with the medtech industry is as important as our partnership with the medical profession and the healthcare system. We base this relationship upon the ethos of innovation, information and independence. I see […]

In 2019, and in every corner of the world, pressing issues affect patients and their way of life. Consequently, this impacts upon their loved ones and personal, professional and social communities. There are conditions and diseases that receive a lot of attention and are broadly recognised and there are those that don’t. Atrial fibrillation (AF,) […]

Given that the number of Europeans aged over 65 will double in the next 50 years, and the number of over 80 year olds will almost triple, it follows that keeping this age group in good health is a particular priority.  However, European healthcare systems are at a tipping point, driven by the increasing burden […]

In September, I chaired a European Parliament roundtable with MEPs and five other cardiac patient organisations on Heart Valve Disease and the Power of Positive Ageing. Our message was simple – heart valve disease is a barrier to active and healthy ageing: early detection, diagnosis and treatment with innovative medical technologies enables positive ageing. Equal […]

This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com. Check out related blogs: Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage, How to create and maintain an ethical culture,Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation, Progress […]

This blog is part of the Early Diagnosis campaign #BeFirst Early diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice.  Read the other […]